Darizmetinib
Darizmetinib (HRX215, HRX-0215) is an MKK4 inhibitor. Inhibition of MKK4 leads to enhancement of the MKK7 and JNK1 signaling pathways, thereby activating the transcription factors ATF2 and ELK1, promoting cell proliferation and liver regeneration.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
457.45
Molecular Formula
C21H17F2N5O3S
Notes
Research use only, not for human use.
Receptor
MAPK | Antiviral
CAS Number
2369583-33-3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
